Articles Vol. 66 No. CĐ14-HNKH BV Giao thông Vận tải 12/01/2026

7. DISEASE MODEL AND SOME LABORATORY INDICATORS OF ATO CYCLE HEMODIALYSIS PATIENTS AT TRANSPORT HOSPITAL IN 2024-2025

Le Thi Thanh Huyen1,2, Bui Sy Tuan Anh1,3, Nguyen Van Hung1,3, Dao Thi Thu Huyen1,3, Bui Ngoc Mai4,5, Pham Xuan Da4,5
1 Transport Hospital Joint Stock Company
2 1) Bệnh viện Giao thông vận tải
3 Bệnh viện Giao thông vận tải
4 VNU – University of Medicine and Pharmacy
5 2) Trường Đại học Y Dược, Đại học Quốc gia Hà Nội
Corresponding author: drdavn@gmail.com
DOI: 10.52163/yhc.v66iCD14.3058
22 Views
16 Downloads
Keywords
chronic hemodialysis, disease pattern, hematological indices, biochemical indices.
Abstract

Objectives: To describe disease patterns and analyze the association between dialysis duration, age, and hematological–biochemical indices in chronic hemodialysis patients.

Methods: A cross-sectional study was conducted on 125 patients at Transport Hospital (2023–2024). Clinical, hematological, and biochemical data were compared between patients with <5 vs. >5 years of dialysis, and multivariate regression was performed with age and dialysis duration.

Results: Hypertension surpassed glomerulonephritis as the leading cause of end-stage renal disease. Patients with shorter dialysis duration had more comorbidities (hypertension 68.3%, diabetes 23.8%). Longer dialysis duration correlated positively with reticulocyte ratio (Coef = 0.03; p<0.001), reticulocyte hemoglobin content (Coef = 0.08; p<0.01), and ferritin (Coef = 28.74; p<0.001). Older age correlated inversely with urea, creatinine, Na⁺, K⁺, and albumin (p<0.05).

Conclusions: The disease spectrum among hemodialysis patients is shifting, with rising prevalence of hypertension and comorbidities. Personalized management strategies should be tailored according to age and hematologic–biochemical indices.

References
[1]
Wang L, et al. Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance. JAMA Intern Med. 2023;183(4):298-310. Google Scholar
[2]
Thurlow JS, et al. Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy. Am J Nephrol. 2021;52(2):98-107. Google Scholar
[3]
Liyanage T, et al. Prevalence of chronic kidney disease in Asia: a systematic review and analysis. BMJ Glob Health. 2022;7(1). Google Scholar
[4]
Nguyễn Lê Thanh Trúc, et al. Tình trạng thiếu máu ở bệnh nhân bệnh thận mạn tại Việt Nam. Tạp chí Y học Việt Nam. 2021. Google Scholar
[5]
Zhang L, et al. Prevalence of chronic kidney disease in China. JAMA Intern Med. 2023;183(4):298-310. Google Scholar
[6]
Thurlow JS, et al. Global Epidemiology of End-Stage Kidney Disease. Am J Nephrol. 2021;52(2):98-107. Google Scholar
[7]
Cockwell P, Fisher LA. The global burden of chronic kidney disease. Lancet. 2020;395(10225):662-664. Google Scholar
[8]
Murali KM, Lonergan M. Breaking the adherence barriers: Strategies to improve treatment adherence in dialysis patients. Semin Dial. 2020. Google Scholar
[9]
Babitt JL, Lin HY. Mechanisms of anemia in CKD. J Am Soc Nephrol. 2012;23(10):1631-1634. Google Scholar
[10]
Fishbane S, Spinowitz B. Update on Anemia in ESRD. Am J Kidney Dis. 2018;71(3):423-435. Google Scholar
[11]
Lin YL, Hsu BG. Assessment of uremic sarcopenia in dialysis patients. Tzu Chi Med J. 2022;34(2):182-191. Google Scholar
[12]
Sun J, et al. Association between serum albumin level and mortality in CKD. Am J Med Sci. 2021;361(4):451-460. Google Scholar
[13]
Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome. Nephrol Dial Transplant. 2002;17 Suppl 11:28-31. Google Scholar